Medicines Co. (NASDAQ: MDCO) announced that it has completed its acquisition of all of the outstanding equity of Annovation Biopharma ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE